Skip to main content
. 2011 Dec 16;26(3):426–433. doi: 10.1038/eye.2011.324

Table 2. Mean number of injections.

  Baseline to 3 months 6 months 9 months 12 months
Bevacizumab (SD) 3 (0.00) 3.21 (0.75) 3.88 (1.12) 4.72 (1.84)
Ranibizumab (SD) 3 (0.00) 3.81 (0.94) 4.61 (1.35) 5.52 (1.54)
Pa   0.36 0.05 0.02
a

On the basis of on student t-test.